Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma?

Glaucoma is a common ocular neurodegenerative disease characterized by the progressive loss of retinal ganglion cells and their axons. It is the most common cause of irreversible blindness. With an increasing number of glaucoma patients and disease progression despite treatment, it is paramount to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Mouhammad, Zaynab Ahmad, Vohra, Rupali, Horwitz, Anna, Thein, Anna-Sophie, Rovelt, Jens, Cvenkel, Barbara, Williams, Pete A., Azuara-Blanco, Augusto, Kolko, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899005/
https://www.ncbi.nlm.nih.gov/pubmed/35264926
http://dx.doi.org/10.3389/fnins.2022.824054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899005/
https://www.ncbi.nlm.nih.gov/pubmed/35264926
http://dx.doi.org/10.3389/fnins.2022.824054

Ejemplares similares